Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.
Galanis E, Okuno SH, Nascimento AG, Lewis BD, Lee RA, Oliveira AM, Sloan JA, Atherton P, Edmonson JH, Erlichman C, Randlev B, Wang Q, Freeman S, Rubin J.
Galanis E, et al. Among authors: edmonson jh.
Gene Ther. 2005 Mar;12(5):437-45. doi: 10.1038/sj.gt.3302436.
Gene Ther. 2005.
PMID: 15647767
Clinical Trial.